For a pharmaceutical strategy promoting health security
The pandemic has put Europe in the mirror, and forced us to reorganise our priorities. We have learned from our
Read more
Industry
Strengthening Europe’s capacity to anticipate and respond rapidly to cross-border health emergencies
In the past 10 years, the world has witnessed some of the deadliest outbreaks of infectious diseases in modern times,
Read more
Ensuring a robust and safe supply chain for pharmaceuticals in Europe
Until March 2020 and the emergence of the COVID-19 pandemic in Europe, the concepts of ‘sovereignty’ and ‘strategic autonomy’, used
Read more
Reinforcing Europe as a centre for pharmaceutical innovation
Europe is home to a rich innovation ecosystem with start-ups, world-class research institutions, top universities for life sciences and many
Read more
Pharmaceutical sector – how to truly achieve strategic resilience
A strong Union needs a strong industrial sector to promote competitiveness, create jobs and guarantee a high quality of life.
Read more
The EIB enables strategic investment, and not just for Europe
At the beginning of 2022, the European Investment Bank formally set up a new development arm: EIB Global. Building on
Read more
Strengthening Europe’s Financial Stability
A European Union that enjoys strategic autonomy needs to have a finical system that supports this autonomy. Therefore, financial stability
Read more
EU space policy and the European space industry play a vital role in the EU and its economy.
Far from being a slogan, the so-called New Space is a concrete phenomenon that is affecting the European Union too,
Read more